GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ENLIE Pharmaceutical JSC (HSTC:BCP) » Definitions » EBIT

ENLIE Pharmaceutical JSC (HSTC:BCP) EBIT : ₫ Mil (TTM As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is ENLIE Pharmaceutical JSC EBIT?

ENLIE Pharmaceutical JSC's earnings before interest and taxes (EBIT) for the six months ended in . 20 was ₫0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.


ENLIE Pharmaceutical JSC EBIT Historical Data

The historical data trend for ENLIE Pharmaceutical JSC's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENLIE Pharmaceutical JSC EBIT Chart

ENLIE Pharmaceutical JSC Annual Data
Trend
EBIT

ENLIE Pharmaceutical JSC Semi-Annual Data
EBIT

Competitive Comparison of ENLIE Pharmaceutical JSC's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, ENLIE Pharmaceutical JSC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ENLIE Pharmaceutical JSC's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ENLIE Pharmaceutical JSC's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where ENLIE Pharmaceutical JSC's EV-to-EBIT falls into.



ENLIE Pharmaceutical JSC EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was ₫ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ENLIE Pharmaceutical JSC  (HSTC:BCP) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

ENLIE Pharmaceutical JSC's annualized ROC % for the quarter that ended in . 20 is calculated as:

ROC % (Q: . 20 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: . 20 ) + Invested Capital (Q: . 20 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

ENLIE Pharmaceutical JSC's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

ROC (Joel Greenblatt) %(Q: . 20 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: . 20  Q: . 20
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=/( ( ( + max(, 0)) + ( + max(, 0)) )/ )
=/( ( + )/ )
=/
= %

where Working Capital is:

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

ENLIE Pharmaceutical JSC's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: . 20 )
=/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ENLIE Pharmaceutical JSC EBIT Related Terms

Thank you for viewing the detailed overview of ENLIE Pharmaceutical JSC's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


ENLIE Pharmaceutical JSC (HSTC:BCP) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
NA6 Street, My Phuoc 2 Industrial Park, Ben Cat district, Binh Duong, VNM
ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.

ENLIE Pharmaceutical JSC (HSTC:BCP) Headlines

No Headlines